Stock Scorecard
Stock Summary for Hims & Hers Health Inc - Class A (HIMS) - $12.50 as of 4/26/2024 9:19:46 PM EST
Total Score
9 out of 29
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for HIMS
Positive earnings growth | |
P/E ratio less than Industry P/E Ratio | |
P/E ratio less than Sector P/E Ratio | |
P/E ratio that is half the growth rate (or less) | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Positive net income past year and 12 trailing months | |
Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for HIMS
Revenue growing by at least 20% average per year over the last 5 years | |
Market Capitalization under 2 billion | |
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for HIMS
Declared an ex-dividend date | |
Forward annual dividend rate greater than 2 | |
Positive net cash position the past year and most recent quarter | |
Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
Current ratio most recent quarter greater than 2 |
Bonus Criteria for HIMS
P/E ratio less than five-year Average P/E ratio | |
Last Price to 52 Week Low Ratio Less Than 1 | |
Total Cash Per Share > Last Day Price | |
P/S Ratio < 1 | |
P/B Ratio < 1 |
Latest News for for HIMS
Financial Details for HIMS
Company Overview |
|
---|---|
Ticker | HIMS |
Company Name | Hims & Hers Health Inc - Class A |
Country | USA |
Description | Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers with licensed healthcare professionals. The company is headquartered in San Francisco, California. |
Sector Name | LIFE SCIENCES |
Industry Name | SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE |
Most Recent Quarter | 12/31/2023 |
Next Earnings Date | 5/6/2024 |
Stock Price History |
|
Last Day Price | 12.50 |
Last Day Price Updated | 4/26/2024 9:19:46 PM EST |
Last Day Volume | 3,594,920 |
Average Daily Volume | 4,648,930 |
52-Week High | 17.16 |
52-Week Low | 5.65 |
Last Price to 52 Week Low | 121.24% |
Valuation Measures |
|
Trailing PE | N/A |
Industry PE | N/A |
Sector PE | 61.73 |
5-Year Average PE | -41.89 |
Free Cash Flow Ratio | 11.68 |
Industry Free Cash Flow Ratio | N/A |
Sector Free Cash Flow Ratio | 30.74 |
Current Ratio Most Recent Quarter | 3.00 |
Total Cash Per Share | 1.07 |
Book Value Per Share Most Recent Quarter | 1.61 |
Price to Book Ratio | 8.69 |
Industry Price to Book Ratio | N/A |
Sector Price to Book Ratio | 22.08 |
Price to Sales Ratio Twelve Trailing Months | 3.43 |
Industry Price to Sales Ratio Twelve Trailing Months | N/A |
Sector Price to Sales Ratio Twelve Trailing Months | 5.16 |
Share Statistics |
|
Total Shares Outstanding | 205,873,000 |
Market Capitalization | 2,573,412,500 |
Institutional Ownership | N/A |
Dividends |
|
Ex-Dividend Date | N/A |
Last Dividend Amount | 0.00 |
Current Dividend Amount | 0.00 |
Dividend Aristocrat? | False |
Trailing Annual Dividend Rate | 0.00 |
Trailing Annual Dividend Yield | 0.00% |
Forward Annual Dividend Rate | 0.00 |
Forward Annual Dividend Yield | 0.00% |
5-Year Dividend Payments Count | 0 |
3-Year Average Dividend Yield | 0.00% |
5-Year Average Dividend Yield | 0.00% |
1-Year Dividend Growth Rate Percentage | 0.00% |
3-Year Dividend Growth Rate Percentage | 0.00% |
5-Year Dividend Growth Rate Percentage | 0.00% |
All-Time Dividend Growth Rate Percentage | 0.00% |
Dividend Payout Ratio | N/A |
Income Statement |
|
Quarterly Earnings Growth YOY | 0.00% |
Annual Earnings Growth | 64.15% |
Reported EPS 12 Trailing Months | -0.11 |
Reported EPS Past Year | 0.00 |
Reported EPS Prior Year | -0.11 |
Net Income Twelve Trailing Months | -23,546,000 |
Net Income Past Year | -23,546,000 |
Net Income Prior Year | -65,678,000 |
Quarterly Revenue Growth YOY | 47.50% |
5-Year Revenue Growth | 80.28% |
Balance Sheet |
|
Total Cash Most Recent Quarter | 220,981,000 |
Total Cash Past Year | 220,981,000 |
Total Cash Prior Year | 179,672,000 |
Net Cash Position Most Recent Quarter | 220,981,000 |
Net Cash Position Past Year | 220,981,000 |
Long Term Debt Past Year | 0 |
Long Term Debt Prior Year | 0 |
Total Debt Most Recent Quarter | 0 |
Equity to Debt Ratio Past Year | 1.00 |
Equity to Debt Ratio Most Recent Quarter | 1.00 |
Total Stockholder Equity Past Year | 344,029,000 |
Total Stockholder Equity Prior Year | 311,741,000 |
Total Stockholder Equity Most Recent Quarter | 344,029,000 |
Options |
|
Put/Call Ratio | 0.13 |
Has Options | Options Chain |
Liquidity Rating | |
Technical Analysis |
|
Yahoo Finance Chart | Yahoo Finance Chart |
MACD | -0.59 |
MACD Signal | -0.27 |
20-Day Bollinger Lower Band | 5.77 |
20-Day Bollinger Middle Band | 11.24 |
20-Day Bollinger Upper Band | 16.71 |
Beta | 0.91 |
RSI | 35.31 |
50-Day SMA | 9.07 |
200-Day SMA | 8.91 |
System |
|
Modified | 4/25/2024 2:22:07 AM EST |